Estimate Recalculated Feb 6, 2025 09:16PM EST
Lawrence Eichenfield does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Verrica Pharmaceuticals Inc., and Forte Biosciences, Inc..
Lawrence Eichenfield's CIK is 0001814892
2021 was Lawrence Eichenfield's most active year for acquiring shares with 3 total transactions. Lawrence Eichenfield's most active month to acquire stocks was the month of May. 2024 saw Lawrence Eichenfield paying a total of $0.00 for 70,000 shares, this is the most they've acquired in one year.
No data available
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!